4DMedical (ASX:4DX), Hansen Technologies (ASX:HSN) and Bravura Solutions (ASX:BVS) operate across respiratory imaging, billing and customer-management software, and wealth-administration technology. Their 2026 company disclosures covered financial results, commercial deployments, recurring software revenue, customer activity and capital-management initiatives.

4DMedical (ASX:4DX)

4DMedical develops respiratory imaging technology used to assess lung function and respiratory conditions. Its platform includes proprietary XV Technology and CT:VQ, with its software integrated into hospital, radiology and medical-imaging workflows.

For FY26, 4DMedical reported operating Revenue of AUD 7.1 million, representing an increase of 21%. Underlying SaaS revenue increased 23%, while gross margins exceeded 90%. The adjusted net loss was AUD 32.9 million.

The company ended FY26 with AUD 278.0 million in cash. Its statutory result included a AUD 164.6 million non-cash expense associated with the fair-value measurement of the Equity component of its Pro Medicus financing facility.

Hansen Technologies (ASX:HSN)

Hansen Technologies provides billing, customer-information and revenue-management software to energy, utilities and communications companies. Its products support customer management, billing, service operations and related processes for customers across international markets.

Hansen Technologies (ASX:HSN) reported FY26 Operating Revenue of AUD 386.5 million. Support and maintenance revenue reached AUD 230.3 million, representing an increase of 13.4%.

Underlying EBITDA was AUD 119.6 million, equivalent to an underlying EBITDA Margin of 31.0%. Cash EBITDA was AUD 106.2 million, while statutory net profit after tax was AUD 47.8 million.

Underlying net profit after tax and Amortisation was AUD 65.9 million. Profit before tax was AUD 62.7 million.

For FY27, Hansen Technologies (ASX:HSN) indicated that recurring support and maintenance revenue remained an area of planned development while the company continued Investment across products and customer programs.

The company also announced a Partnership with InvoiceCloud in August 2026 to integrate digital payment capabilities with Hansen's Utility billing and customer-management software.

Bravura Solutions (ASX:BVS)

Bravura Solutions provides technology to Wealth managers, pension providers, fund administrators and other financial-services organisations. Its platforms support wealth administration, pensions, funds administration and digital financial-services processes across several international markets.

Bravura Solutions (ASX:BVS) reported FY26 revenue from customers of AUD 282.6 million. Recurring Revenue was AUD 165.0 million.

Cash EBITDA reached AUD 77.1 million, while the cash EBITDA margin was 27.3%. Underlying net profit after tax was AUD 63.1 million. Bravura ended the financial year with AUD 50.3 million in cash and no drawn debt.

Bravura declared a final ordinary Dividend of 8.31 cents per share and a Special Dividend of 6.69 cents per share as part of its FY26 results. Total FY26 dividends amounted to 25.23 cents per share.

The company also announced an on-market share buyback of up to AUD 50 million, commencing from 31 August 2026 and scheduled to operate for up to 12 months.

2026 Business Updates

4DMedical reported higher operating revenue and scan volumes during FY26 alongside expansion of its commercial imaging network. Its year-end disclosures recorded 540 deployed SaaS sites and 344,075 scans during the financial year.

Hansen reported AUD 386.5 million in operating revenue and AUD 230.3 million in support and maintenance revenue, alongside underlying EBITDA of AUD 119.6 million.

Bravura reported AUD 282.6 million in revenue from customers and AUD 77.1 million in cash EBITDA. Its 2026 company announcements also included an on-market buyback and admission to trading on AIM.